Induction of myocardial nitric oxide synthase by Coxsackie B3 virus in mice

European Journal of Clinical Investigation

Volumn 29, Issue 8, 1999, Pages 700-707

  Robinson, N M K ^a,d   Zhang, H Y ^b   Bevan, A L ^b   De Belder, A J ^a   Moncada, S ^c   Martin, J F ^b   Archard, L C ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

Cytokines; Myocardium; Nitric oxide

Indexed keywords

CYTOKINE; HEART ENZYME; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS MYOCARDITIS;

EID: 0032810897     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00505.x     Document Type: Article

References (42)

1. 1 Grist NR, Bell EJ, Assaad F. Enteroviruses in human disease. Prog Med Virol 1978; 24: 114-57.
2. 2 Martin TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 1994; 74: 182-8.
3. 3 Bowles NE, Richardson PJ, Olsen EGJ, Archard LC. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986; i: 1120-2.
4. 4 Easton AJ, Eglin RP. The detection of coxsackievirus RNA in cardiac tissue by in situ hybridization. J Gen Virol 1988; 69: 285-91.
5. 5 Jin O, Sole MJ, Butany JW, Chia W-K, McLaughlin PR, Liu P, Liew C-C. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 1990; 82: 8-16.
6. 6 Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 33: 664-6.
7. 7 Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249-58.
8. 8 Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Prac Natl Acad Sci USA 1985; 82: 7738-42.
9. 9 Kandolf R, Hofschneider PH. Molecular cloning of the genome of a cardiotropic coxsackie B3 virus full length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci USA 1985; 82: 4818-22.
10. 10 Zhang HY, Yousef GE, Cunningham L, Blake NW, Ou Yang X, Bayston TA, et al. Attenuation of a reactivated cardiovirulent coxsackie B3: the 5′-nontranslated region does not contain major attenuation determinants. J Med Virol 1993; 41: 129-37.
11. 11 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 1987; 162: 156-9.
12. 12 Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 1992; 267: 6370-4.
13. 13 Palmer RMJ, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993; 193: 398-405.
14. 2+-independent nitric oxide synthases. FEBS Lett 1991; 291: 145-9.
15. 15 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
16. 16 Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991; 41: 485-90.
17. 17 Billiar TR, Curran RD, Harbrecht BG, Stadler J, Williams DL, Ochoa JB, et al. Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes. Am J Physiol 1992; 262: 1077-82.
18. 18 Henke A, Mohr C, Sprenger H, Graebner C, Stelzner A, Nain M, et al. Coxsackievirus B3-induced production of tumor necrosis factor-a IL-1b and IL-6 in human monocytes. J Immunol 1992; 148: 2270-77.
19. 19 Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-a in the adult mammalian heart. J Clin Invest 1993; 92: 2303-12.
20. 20 Hosenpud JD, Campbell SM, Mendelson DJ. Interleukin-1 induced myocardial depression in an isolated beating heart preparation. J Heart Transplant 1989; 8: 460-4.
21. 21 Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387-9.
22. 22 Freeman GL, Colston JT, Zabalgoitia M, Chandrasekar B. Contractile depression and expression of proinflammatory cytokines and iNOS in viral myocarditis. Am J Physiol 1998; 274: H249-58.
23. 23 de Belder AJ, Radomski MW, Why HJ, Richardson PJ, Martin JF. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy myocarditis and postpartum cardiomyopathy but not in ischaemic or valvular heart disease. Br Heart J 1995; 74: 426-30.
24. 24 Hooper DC, Ohnishi ST, Kean R, Numagami Y, Dietzschold B, Koprowski H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc Natl Acad Sci USA 1995; 92: 5312-16.
25. 25 Zheng YM, Schafer MK-H, Weihe E, Sheng H, Corisdeo S, Fu ZF, et al. Severity of neurological signs and degree of inflammatory lesions in the brains of rats with borna disease correlate with the induction of nitric oxide. J Virol 1993; 67: 5786-91.
26. 26 Robinson NM, Westmore KR, Martin JF, Emson E, Charles IG. Inducible nitric oxide synthase gene transcription and protein activity in the rat heart during endotoxaemia. Biochem Biophys Res Commun 1997; 231: 211-16.
27. 27 Balligand J-L, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem 1994; 269: 27580-8.
28. 28 Balligand J-L, Ungureanu D, Simmons WW, Kobzik L, Lowenstein CJ, Lamas S, et al. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1b and IFN. Am J Physiol 1995; 268: H1293-303.
29. 29 Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990; 275: 87-90.
30. 30 Yoshizumi M, Perrella MA, Burnett JC, Lee M-E. Tumor necrosis factor downregulates an endothelial nitric oxide synthase messenger RNA by shortening its half-life. Circ Res 1993; 73: 205-9.
31. 31 de Belder A, Radomski M, Hancock V, Brown A, Moncada S, Martin J. Megakaryocytes from patients with coronary atherosclerosis express the inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 1995; 15: 637-41.
32. 32 Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
33. 33 Schmidt HHHW, Walter U. NO at work. Cell 1994; 78: 919-25.
34. 34 Hibbs JB, Taintor RR, Vavrin Z, Granger DL, Drapier JC, Amber IJ, et al. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine. a molecular mechanism regulating cellular proliferation that targets intracellular iron. In: Moncada S, Higgs EA, editors. Nitric oxide from L-arginine: a bioregulatory system. Amsterdam: Elsevier; 1990. p. 189-223.
35. 35 Croen KD. Evidence of an antiviral effect of nitric oxide. J Clin Invest 1993; 91: 2446-52.
36. 36 Karupiah G, Xie Q-w, Buller ML, Nathan C, Duarte C, MacMicking JD. Inhibition of viral replication by interferon induced nitric oxide synthase. Science 1993; 261: 1445-8.
37. 37 Karupiah G, Harris N. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J Exp Med 1995, 181: 2171-9.
38. 38 Zaragoza C, Ocampo C, Saura M, Leppo M, Wei XQ, Quick R, et al. The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc Natl Acad Sci USA 1998; 95: 2469-74.
39. 39 Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-64.
40. 40 Mikami S, Kawashima S, Kanazawa K, Hirata K, Hotta H, Hayashi Y, et al. Low-dose N-Nitro-L-Arginine methyl ester treatment improves survival rate and decreases myocardial injury in a murine model of viral myocarditis induced by coxsackievirus B3. Circ Res 1997; 81: 504-11.
41. 41 Lowenstein CJ, Hill SL, Lafond-Walker A, Wu J, Allen G, Landavere M, et al. Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 1996; 97: 1837-43.
42. 42 Hiraoka Y, Kishimoto C, Takada H, Nakamura M, Kurokawa M, Ochiai H, et al. Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase. J Am Coll Cardiol 1996; 28: 1610-15.